1 |
Klebsiella pneumoniae: estudo molecular dos fatores de resistência e caracterização ultra-estrutural da ação de antibióticos β-lactâmicosVERAS, Dyana Leal 31 January 2009 (has links)
Made available in DSpace on 2014-06-12T18:30:31Z (GMT). No. of bitstreams: 2
arquivo3565_1.pdf: 5205665 bytes, checksum: d3f5d67863a34c85659602984a49cb65 (MD5)
license.txt: 1748 bytes, checksum: 8a4605be74aa9ea9d79846c1fba20a33 (MD5)
Previous issue date: 2009 / Conselho Nacional de Desenvolvimento Científico e Tecnológico / Klebsiella pneumoniae é uma enterobactéria responsável por uma alta incidência
de infecções hospitalares, causadas geralmente por linhagens portadoras de
multirresistência e produtoras de -lactamases de amplo espectro (ESBL). Este trabalho
teve como objetivo determinar os genes envolvidos na formação de beta-lactamases
clássicas e ESBLs em isolados de K. pneumoniae de Recife-PE, Brasil, assim como
investigar o efeito ultra-estrutural causado por diferentes concentrações de antibióticos
beta-lactâmicos, em isolados de K. pneumoniae produtores de diferentes tipos de betalactamases.
Foram analisados 52 isolados de K. pneumoniae quanto a presença dos
genes blaSHVe blaTEM, originados da microbiota normal e de infecções na comunidade e
hospitalares e para a investigação do gene blaCTX-M foram utilizados 19 isolados clínicos
de K. pneumoniae que apresentaram resistência a cefalosporinas de terceira geração ou
ao aztreonam. Os MICs dos isolados foram determinados frente aos antibióticos
ceftazidima, cefotaxima e aztreonam. Dois isolados de infecção nosocomial de K.
pneumoniae foram submetidos a diferentes Sub-MICs de ceftazidima, cefotaxima e
aztreonam para a análise pela Microscopia Eletrônica de Transmissão e de Varredura
(MET e MEV). O gene blaSHV foi detectado em 16 isolados hospitalares, 4 da
comunidade e 9 da microbiota, enquanto o gene blaTEM foi detectado em 18 isolados
hospitalares, 4 da microbiota e 2 da comunidade. Através do sequenciamento de DNA,
o gene blaCTX-M2 foi detectado em três isolados resistentes tanto a ceftazidima quanto a
cefotaxima. Adicionalmente, foi encontrada uma nova variante SHV em um dos
isolados e a presença de duas variantes anteriormente relatadas a SHV-28 e a SHV-108.
As análises dos 2 isolados de K. pneumoniae pela MET e MEV mostraram grandes
alterações morfológicas e ultra-estruturais dos isolados, quando submetidos aos
diferentes Sub-MICs de ceftazidima e cefotaxima. *Nossos resultados mostram que
isolados de K. pneumoniae portadores de diferentes β-lactamases e resistentes a
diferentes antimicrobianos podem sofrer alterações ultra-estruturais significativas
quando submetidos a Sub-MICs da droga, o que poderia possibilitar uma melhor
atuação do sistema imune de um paciente infectado com esta espécie bacteriana
|
2 |
SHV β-lactamases : DNA diagnostics and evolutionHammond, David Scott January 2006 (has links)
TEM and SHV β-lactamases are the most prevalent β-lactamases among Gram-negative bacteria. The introduction and widespread use of expanded-spectrum antibiotics, particularly third generation cephalosporins, has led to the evolution of bacterial strains expressing extended spectrum β-lactamases (ESBLs). ESBLs emerge by genetic point mutation from non-extended spectrum precursors. It was found that multiple β-lactamase families within single isolates complicate the process of detecting the resistance status of isolate using non-quantitative DNA diagnostic methods. Preliminary phenotypic characterisation of probable β-lactamase enzyme family types present in 100 isolates from the Asia-Pacific and South African locales showed that single isolates frequently contained multiple β-lactamase families. SHV, TEM, AMPC and CTX-M β-lactamase families were detected in these isolates using PCR detection methods. Ninety-eight percent of all isolates tested contained as least one β-lactamase gene, with up to four to β-lactamase gene families found to co-exist in single isolates. Kinetic PCR methods for interrogating the polymorphic sites at blaSHV codons 238 & 240 and blaTEM codons 164, 238, 240 as well as promoter polymorphism were developed. A high proportion of blaSHV 238 and 240 mutant alleles was found to correlate with cefotaxime, ceftazidime and aztreonam resistance levels. In an attempt to understand the molecular basis for the co-existence of multiple blaSHV alleles within single isolates, the blaSHV promoter region was cloned from one ESBL expressing isolate. Experimental results showed that blaSHV can exist downstream of two different promoters within a single isolate. Both promoters have previously been reported, and differ by the presence or absence of IS26, which results in a change in the transcription initiation site. The blaSHV gene copy numbers in cis with the different promoters were measured, and it was found that the copy number of the IS26::blaSHV promoter was positively correlated with resistance levels. Cloning and analysis of PCR products showed that different blaSHV variants existed in cis with promoters in individual isolates. However, mutant genes were more abundant downstream of the IS26 promoter. There were no ESBL+ isolates without this promoter. It was concluded that blaSHV in cis with the IS26 promoter is located on an amplifiable replicon, and the presence of the IS26 insertion may facilitate the acquisition of an ESBL+ phenotype. To further confirm the role of IS26 in resistance acquisition, ESBL negative isolates were subjected to serial passage in vitro evolution experiments and fluctuation assays. Results confirm that the insertion of the IS26 element upstream of blaSHV is positively correlated with the ability to exhibit an ESBL phenotype, when such isolates also contain the critical G238S substitution. It was also found that IS26 can catalyse the duplication and mobilisation of blaSHV within an isolate. Fluctuation experiments have shown that the frequency at which such genomic events occur resulting in ESBL phenotypes is extremely low and requires many generations of selection under sub-lethal conditions. A survey of a geographically diverse set of isolates has shown that IS26-blaSHV was found in all of the bacterial populations surveyed. However, it does not appear to be exclusively associated with SHV-mediated ESBL production.
|
Page generated in 0.0232 seconds